Independently HPLC-Verified Purity Same-Day Shipping Free Shipping on Orders $250+ Lot-Specific COA — Published and Open No Reseller Markup — Direct-Source Pricing
Stock the Shelfthrough Oct 11 40% off everythingUp to 50% on 10+ of the same vial
Metabolic Research Peptides

Semaglutide (GLP-1S)

Synthetic GLP-1 Receptor Agonist

Price range: $44.39 through $65.39
No reseller markup

You save from $29.60 Stock the Shelf applied automatically at checkout — no code needed

Direct-source pricing: Solira works through manufacturing partnerships to reduce reseller markup while maintaining independent third-party testing and lot-specific COA verification.

Bundle & save Stock the Shelf

Order in … for same-day shipping

Estimated delivery Wed, Oct 14 – Tue, Oct 20

In stock — ships same business day
We acceptVisaMastercardAmerican ExpressDiscover· Bitcoin · Zelle
Secure Checkout HPLC-Verified Same-Day Shipping

Quick facts

Type
Synthetic GLP-1 receptor agonist (long-acting analog)
Purity
HPLC-verified (see COA)
Testing
Third-party HPLC + mass spectrometry
Form
Lyophilized powder
Shipping
Same-day (orders before 3 PM ET)
Use
In-vitro laboratory research only

The Solira Take

GLP-1S is a GLP-1 receptor agonist peptide with ~94% sequence homology to human GLP-1. Characterized in extensive preclinical literature on incretin-pathway and glucose-homeostasis mechanisms.

COA / Testing

Every batch of product sold by Solira undergoes independent third-party analytical testing to verify identity and purity, performed by Chromate.

  • HPLC purity analysis — confirms compound purity
  • Mass spectrometry — identity confirmation via molecular weight verification
  • Lot-specific documentation — each COA corresponds to the specific manufacturing lot

COA available upon request. Contact us for lot-specific documentation.

Description

Semaglutide (GLP-1S) is a synthetic long-acting glucagon-like peptide-1 (GLP-1) receptor agonist supplied as a lyophilized powder for laboratory research. The compound features a modified peptide backbone with a fatty-acid side chain that extends its half-life relative to native GLP-1.

Solira supplies Semaglutide exclusively for in vitro research and preclinical investigation. Each batch is independently verified by HPLC and mass spectrometry.

Product Specs
Physical FormLyophilized powder
AppearanceWhite to off-white powder
PurityHPLC-verified (see COA)
Molecular FormulaC187H291N45O59
Molecular Weight4113.58 g/mol
CAS Number910463-68-2
Amino Acid SequenceHis-Aib-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys(γGlu-2xOEG-C18 diacid)-Glu-Phe-Ile-Ala-Trp-Leu-Val-Arg-Gly-Arg-Gly-OH
PubChem CID56843331
Research Applications
  • Investigated in preclinical models for GLP-1 receptor signaling and downstream cAMP pathways.
  • Studied in controlled in vitro systems for insulinotropic activity on pancreatic beta-cell lines.
  • Used in laboratory research examining satiety signaling and gastric emptying pathways.
  • Evaluated in preclinical models for receptor binding affinity and ligand-receptor kinetics.
Storage & Handling

Store sealed, dry, and protected from light.
Long-term storage: -20°C recommended.
Short-term storage: 2-8°C acceptable.
Reconstitution: Use sterile technique with bacteriostatic water.
Post-reconstitution: Stable up to 30 days at 2-8°C.

All handling instructions are intended for laboratory use only.

Sold to qualified researchers for laboratory use only. These products have not been evaluated by the FDA, are not intended to diagnose, treat, cure or prevent any disease, and are not for human, veterinary, or food use in any form. The purchaser is responsible for the lawful and proper use of any compound purchased.

Researcher verification

Solira supplies research peptides to qualified researchers and laboratories for in vitro and laboratory use. Please confirm before continuing.

By proceeding you affirm the statements above are true. These products are not for human or veterinary use, not for use in diagnostic procedures, and have not been evaluated by the U.S. Food and Drug Administration. Full disclaimer.

Scroll to Top